Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Plos One|October 21, 2024
Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathwaysWillemijn Faber, Alexander B StillebroerCancer Imaging : the Official Publication of the International Cancer Imaging Society|December 7, 2007
Radiolabeled antibodies in renal cell carcinomaAlexander B Stillebroer, Egbert Oosterwijk, Wim J G Oyen, et al.European Urology|April 3, 2010
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapyAlexander B Stillebroer, Peter F A Mulders, Otto C Boerman, et al.Nederlands Tijdschrift Voor Geneeskunde|July 31, 2019
[A chancre instead of cancer]Fieke M Prins, M T W T Lock, Alexander B Stillebroer, et al.World Journal of Urology|March 22, 2026
Experience of 5 years adjustable continence therapy (ProACT): the surgical learning curve and patient outcomesLisa M de Zeeuw, Coen H H Christiaans, Sebastiaan Remmers, et al.Neuromodulation : Journal of the International Neuromodulation Society|June 11, 2022
Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of SuccessRosa L Coolen, Jan Groen, Alexander B Stillebroer, et al.Cancer Biotherapy & Radiopharmaceuticals|May 24, 2013
ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in miceAlexander B Stillebroer, Gerben M Franssen, Peter F A Mulders, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2014
Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody GirentuximabConstantijn H J Muselaers, Alexander B Stillebroer, Mark Rijpkema, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imagingAlexander B Stillebroer, Catharina M L Zegers, Otto C Boerman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenibIngrid M E Desar, Alexander B Stillebroer, Egbert Oosterwijk, et al.Pageof 2